Arg Medtech
Manufacturing · Switzerland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Route De La Corniche 4, Epalinges, Vaud,...Website
www.argamedtech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Arg Medtech
Argá Medtech SA specializes in developing innovative cardiac ablation systems, focusing on a next-generation, non-thermal Pulsed Field Ablation (PFA) technology. Their unique system promises significant advantages over existing thermal energy sources, aiming to improve safety, effectiveness, and long-term outcomes for patients with atrial fibrillation. The company targets healthcare providers and physicians involved in the treatment of heart arrhythmias. With a commitment to enhancing patient care, Argá Medtech addresses the challenges faced in current cardiac ablation therapies.Explore more
Popular SearchesArg Medtech SAArga Medtech Usa IncArgá Medtech SAArg MedtechArga MedtechSIC Code 38,384NAICS Code 33,339Show moreArg Medtech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Arg Medtech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Arg Medtech
Arg Medtech, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Arg Medtech had a recent Job posting/layoffs
Earning: See what the market has to say on Arg Medtech recently announced quarterly report
Check out if Arg Medtech is spiking on competitors!
Product Launch: Get notified when Arg Medtech launches new products
Funding: Get notified immidiatlly once Arg Medtech has new funding data
Check if Arg Medtech has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Arg Medtech as Masked Content
Find 3 more new buyers
Compare Similar Companies to Arg Medtech
Compare insights from companies similar to Arg Medtech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Arg Medtech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Arg Medtech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Arg Medtech.
Arg Medtech financials insights
Gather financial insights about Arg Medtech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series B
$58.5M
Arg Medtech Tech Stack
A closer look at the technologies used by Arg Medtech
See more technologies
Arg Medtech News & Media
Argá Medtech Announces First Enrollments in COHERENT-AF IDE Clinical Trial
- Second generation pulsed field ablation system will be evaluated in paroxysmal and persistent atrial fibrillation patients to gain FDA approval - LAUSANNE, Switzerland and SAN DIEGO, Sept. 18, 2025 /PRNewswire/ -- Argá Medtech, developers of the Coherent Sine-Burst Electroporation™...Argá Medtech closes oversubscribed Series B funding for pulsed field ablation tech
Argá Medtech today announced it closed a €54 million oversubscribed Series B funding round to support its pulsed field ablation technology.Argá Medtech Initiates First-in-Human Trial to Assess the Safety and Effectiveness of Coherent Sine Wave Electroporation in Patients with Atrial Fibrillation
EPALINGES, Switzerland, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Argá Medtech announced today that it has begun enrollment in their First-in-Human Clinical Trial “Coherent Sine Burst Electroporation (CSE) System Pilot Study in Patients with Atrial Fibrillation (BURST-AF)”. The study is designed to test the acute safety and efficiency of the Argá Medtech CSE Ablation System in the treatment of atrial fibrillation (AFib). The first five patients, four with paroxysmal and one with persistent AFib, were suArgá Medtech Shows Promise for New Cardiac Ablation Technology at 2022 Heart Rhythm Society Annual Meeting
Argá Medtech’s next-generation non-thermal cardiac ablation system shows promise in improving precision, speed and flexibility in treating atrial fibrillationPreliminary feasibility study results demonstrate the company’s Coherent Sine-Burst Electroporation (CSE) Pulsed Field Ablation platform’s ability to titrate lesion depth using sinusoidal waveforms LAUSANNE, Switzerland and SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- Argá Medtech, a company developing Coherent Sine-Burst Electroporation (
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Arg Medtech
Sign Up For FreeTo access detailed company insights
Argá Medtech SA specializes in developing innovative cardiac ablation systems, focusing on a next-generation, non-thermal Pulsed Field Ablation (PFA) technology. Their unique system promises significant advantages over existing thermal energy sources, aiming to improve safety, effectiveness, and long-term outcomes for patients with atrial fibrillat... Read More
